Introduction: As the number of elderly end-stage renal disease patients lacking suitable vessels for arteriovenous fistula (AVF) is increasing, indications for tunnel cuffed catheters (TCCs) may be expanding. This study aimed to clarify changes over time in the number of patients with TCC and indications for TCCs. Methods: This single-center retrospective study analyzed 143 catheters for 95 patients who inserted TCCs between July 2005 and July 2017. Patients were divided into two groups (early-and late-phase groups) based on the median observational period. Demographic data and clinical information were then compared. Findings: Fifty TCCs were inserted in the early phase group, and 93 TCCs were inserted in the latephase group. The late-phase group was older (77 vs. 70 years; P = 0.003) and showed a higher frequency of hypertensive nephropathy (29% vs. 14%; P < 0.05) and a lower frequency of a history of cardiovascular disease (52.7% vs. 70.0%; P = 0.045). In the late-phase group, indications for bridge vascular access (0% vs. 11.8%; P < 0.05) or severe cardiac dysfunction (8.0% vs. 20.5%; P < 0.05) were increased. In addition, the late-phase group showed increases in percentage of patients with the catheter inserted in the femoral vein (10.0% vs. 23.7%; P = 0.047), nephrologists performing catheter insertion (56.0% vs. 87.1%; P < 0.001), and the patients who underwent superficialization of the brachial artery (28.0% vs. 46.2%; P = 0.034). Significant differences in catheter survival, incidence of complications, reasons for catheter removal, or incidence of catheter-related infection were not observed between groups. Discussion: Patients with indications for TCC may be increasing due to an increase in elderly endstage renal disease patients whose activities of daily living have decreased. In addition, indications for bridge vascular access were widely accepted in the late-phase group.
INTRODUCTION
Vascular access (VA) correlates with mortality in hemodialysis (HD) patients, and catheters and arteriovenous graft (AVG) show a higher risk of death compared to arteriovenous fistula (AVF). 1, 2 The Dialysis Outcomes and Practice Patterns (DOPPS) Study showed that the percentage of HD patients using catheters is low in Japan and the percentage of using AVF is high, and catheter utilization did not change during the observational period. 3 Conversely, catheter utilization in European countries such as Germany, Italy, France, and Spain has increased about twofold to threefold within the period of the DOPPS study. In the United States Renal Data System, catheters have been reported to be used in 19.4% of prevalent hemodialysis patients. 4 A survey on the condition of VA was conducted by the Japan Society for Dialysis Therapy in 2008, showing that the proportion of patients using tunneled cuffed catheters (TCCs) was only 0.5% (899 patients). 5 However, a survey of 1524 Japanese HD facilities published in 2015 showed that 506 facilities were managing patients using TCC, with 1174 patients using TCC at the 500 facilities that disclosed the numbers of patients. 6 Although that survey had only collected data from about one-third of nationwide dialysis facilities, the clear suggestion was that patients using TCC are increasing rapidly in Japan.
According to the Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis by the Japanese Society for Dialysis Therapy, 7 TCCs are applicable for patients in whom AVF/AVG cannot be created (due to a lack of suitable vessels), patients whose TCC is considered the most appropriate as VA (contracture in the limbs, dementia making cannulation difficult, or where there is high risk of needle removal during dialysis) and pediatric HD patients. However, TCCs are recognized as bridging VA to be used while an AVF/AVG or peritoneal access matures, as VA while waiting for transplantation, and as VA for severe cardiac dysfunction in Europe. 8 TCC can thus be used in a wide variety of patients. This study aimed to clarify changes over time in the number of patients and indications for TCC.
MATERIALS AND METHODS
A total of 143 catheters in 95 patients for whom TCCs were inserted between July 2005 and July 2017 were analyzed in this single-center retrospective study. This study was approved by the medical ethics committees at St. Marianna University School of Medicine Hospital (No. 3907). We divided patients into two groups based on the median observational period: the early phase group, from July 1, 2005 to June 31, 2011; and the latephase group, from July 1, 2011 to June 31, 2017. We then compared demographic data (number of patients, number of catheters, age, and sex), clinical information (etiology of renal failure, presence of diabetic mellitus, history of cardiovascular disease, and vintage of dialysis), indications for catheter, site of catheter insertion, operator, combined use with superficialization at the brachial artery, complications due to catheter insertion, catheter survival, reason for catheter removal and incidence of catheter-related infection. Indications for catheter were classified into a lack of suitable vessels for AVF, severe cardiac dysfunction, bridge VA or others. Patients were retrospectively evaluated after discharge and the following patient information was assessed: death, catheter removal (catheter-related infection, catheter dysfunction or accidental catheter removal), AVF/AVG maturation, recovery of renal function or kidney transplantation. Catheter-related infection was defined as exit-site/tunnel infection or catheter-related sepsis. Catheter dysfunction was defined as inadequate extracorporeal flow or high pressure at venous side. The incidence of catheter-related infection was calculated and expressed as number of episodes per 1000 patient days. (1 g) was given as antibiotic prophylaxis before catheter insertion. First, puncture of the internal jugular or femoral vein was performed under ultrasonic guidance after local anesthesia. Second, the guidewire was advanced to the appropriate position under fluoroscopy. Third, a subcutaneous tunnel was created and the catheter was passed through a tunnel using a tunneler equipped with a catheter kit. Finally, the dilator with combined sheath was inserted over the guidewire, which was removed. The catheter was then inserted through the sheath, which was peeled away. 
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Statistical analysis
RESULTS
Characteristics of the study population are shown in Table 1 . Although 50 TCCs were placed for 30 patients in the early phase, 93 TCCs were placed for 67 patients in the late phase. Two of the patients in the early phase required reinsertion of catheters in the late phase. Thirtyfour patients received TCC insertion as the initial access in the early phase, compared to 58 patients in the latephase. The late-phase group was older than the early phase group (77 years vs. 70 years, P = 0.003). The proportion of males was higher in the early phase group, whereas the proportion of females was higher in the latephase group. Etiologies of renal failure differed significantly between early-and late-phase groups, with the percentage of hypertensive nephropathy significantly higher in the late-phase group than in the early phase group (29% vs. 14%, P < 0.05). Although the presence of diabetes mellitus did not differ between groups, history of cardiovascular disease was higher in the early phase group than in the late-phase group (70.0% vs. 52.7%; P = 0.045). The vintage of dialysis tended to be longer in the late-phase group than in the early phase group, but no significant difference was observed. Use of TCC as bridge VA (0% vs. 11.8%; P < 0.05) or indication to severe cardiac dysfunction (8.0% vs. 20.5%; P < 0.05) was increased in the late-phase group. In addition, the late-phase group showed increases in the percentage of patients with insertion of the catheter in the femoral vein (23.7% vs. 10.0%; P = 0.047), the percentage of catheter insertions performed by nephrologists (87.1% vs. 56.0%; P < 0.001), and the percentage of patients who underwent superficialization of the brachial artery (46.2% vs. 28.0%; P = 0.034). Fifteen of the 143 catheter 
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insertions resulted in complications, comprising arterial puncture in four patients, hematoma in five patients, incorrect insertion into the mediastinum in one patient, mediastinal hematoma in one patient, and primary failure in four patients. No difference in the incidence of complications was seen between groups (16.0% vs. 7.5%; P = 0.115). In our study, the 90-day catheter survival rate was 56.4% ( Figure 1 ). According to the KaplanMeier method, significant difference in catheter survival was not observed between early phase and late-phase groups after applying the log-rank test (P = 0.679) (Figure 2 ). The reason for catheter removal is shown in Table 2 . Catheter removals for unfavorable reason included catheter-related infections for 19 catheters, catheter dysfunction for 32 catheters, and accidental catheter removal for five catheters. Among 19 patients with catheter-related infection, 10 patients had exit sites/tunnel infections, and nine patients had catheter-related sepsis. Furthermore, among 32 patients with catheter dysfunction, 28 patients showed inadequate extracorporeal flow, and four patients displayed high pressure at venous side. In contrast, planned catheter removals included bridging VA in 16 patients, recovery of renal function in three patients, and kidney transplantation in one patient. Significant differences in reasons for catheter removal were not observed between groups. The incidence of catheter-related infection was 0.462/1000 patient days for the whole study period. In addition, the incidence of catheter-related infection was 0.500/1000 patient days and 0.438/1000 patient days in the early phase and late-phase, respectively. The 90-day catheterrelated infection-free survival was 93.0% ( Figure 3) . According to the Kaplan-Meier method, significant difference in catheter-related infection-free survival was not observed between early phase and late-phase groups after applying the log-rank test (P = 0.544) (Figure 4) . After catheter insertion, 19 patients died in the early phase and 34 patients died in the late phase.
DISCUSSION
The number of patients using TCC was increased in the late phase, and patients who inserted TCC were older. Hinoshita et al. reported that more than 2000 Japanese patients might be using TCC. 6 If this is true, patients using TCC will have doubled in just a few years. A recent report indicated that the use of catheters is also increasing in Canada, and the high rate of catheter utilization is affected by the elderly patients at the beginning of dialysis. 9 In Japan, not only the increase in elderly dialysis patients but also the increase in long-term dialysis patients (patients with history of dialysis ≥20 years comprise 7.9% of all dialysis patients) and the increase in diabetic patients (diabetic nephropathy accounted for 37.6% of primary diseases) are major problems. 10 Against such a background, patients for whom AVF cannot be created using autologous vessels are increasing. 7 In our study, although significant difference was not observed between the two groups in terms of the presence of diabetes mellitus, history of cardiovascular disease was higher in the early phase. Furthermore, vintage of dialysis tended to be longer in the late-phase group. Woodside et al. reported that older age was associated with a lower AVF maturation rate, and longer vintage of dialysis, female sex, cardiovascular disease and diabetes mellitus was also associated with lower rate of successful AVF maturation. 11 Our study suggests that the percentage of bridge VA increased as AVF maturation had been insufficient.
The TCC is inserted through the internal jugular vein in most patients. However, catheter insertion into the femoral or iliac vein was also reported in 2009. 12 In recent years, Wang et al. reported that catheters were inserted into 70 elderly HD patients and good clinical courses were obtained. 13 We also performed catheter insertion into the femoral vein for long-term bedridden patients. In other words, our study implies that the number of frail patients who require catheter insertion into the femoral vein is increasing. Catheter insertion by nephrologists was also increased in the late phase. In Japan, interventional nephrologists are reportedly creating VA in many facilities. 14 In addition, Silva et al. reported that the number of TCCs increased as nephrologists became involved in catheter insertion. 15 Although the number of catheter insertions by nephrologists was increased, the incidence of complications remained unchanged, so we considered catheter insertion by nephrologists as safe. Moreover, patients who Figure 3 Catheter-related infection-free survival for all patients. Figure 4 Catheter-related infection-free survival divided by early phase and late-phase groups. The log-rank test shows no significance difference between the early phase and latephase groups. 8 The risk of bleeding due to TCC insertion has been reported as extremely low. 16 Although hematoma and arterial puncture were observed in nine patients, no bleeding requiring blood transfusion was encountered in our study. Incorrect insertion into the mediastinum and mediastinal hematoma was observed in one patient each. A patient who developed mediastinal hematoma underwent thoracotomy by vascular surgeons and then healed. The patient who was not inserted correctly in the mediastinum cured by removing without a surgical procedure.
Several reports have examined the patency of TCC in recent years. Raheem et al. reported a 90-day catheter survival rate of 77%. 17 Similarly, Shingarev et al. reported a 3-month catheter patency rate of 69%. 18 Catheter survival in our patients was slightly lower than those reports. However, some studies have described median catheter patency >300 days. 19, 20 Moreover, Shi et al. reported extremely good catheter survival (median catheter survival for TCC, 45.0 months). 21 However, that study had only a few subjects, excluded bridge VA, and the age of subjects was younger than in our study. Low catheter survival in our study was because all catheter removal (including planned catheter removal) or death of the catheter was analyzed as an event. The incidence of catheter-related infection has been reported as 0.3-1.0 per 1000 patient days. 21, 22 We observed a relatively low incidence of catheter-related infection and the incidence did not differ between the early phase and late-phase groups. Of the 95 TCC-inserted patients, 53 (55.8%) died within the whole study period. The reason for the high mortality was not only the study population of elderly patients but also because of the relatively short vintage of dialysis, the presence of acute kidney injury requiring dialysis patients was also suggested.
This study had several limitations. First, the study was a single-center retrospective observational study, and the sample size was relatively small. Second, the indications for catheters may have differed depending on the attending nephrologist. Our facility did not provide a clear definition of indications for TCC. Third, we cannot demonstrate the utility of TCC, because we did not compare other Vas in term of patency rate and incidence of infectious diseases. A prospective multicenter collaborative research is expected to clarify the usefulness and safety of TCC in many patients.
CONCLUSION
Patients with TCC indications are increasing due to an increase in elderly end-stage renal disease patients. In addition, the indication for bridging access was widely accepted. In the future, if catheters with a higher patency rate and lower infection rate are developed, indications may expand even more.
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